Skip to content

Clinical Study of Fuling Sini Decoction on Intervention of Septic Cardiomyopathy and Immune Paralysis

Clinical Study of Fuling Sini Decoction on Intervention of Septic Cardiomyopathy and Immune Paralysis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045549
Enrollment
Unknown
Registered
2021-04-19
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Cardiomyopathy

Interventions

Sponsors

Beijing University of Chinese Medicine Shenzhen Hospital (Longgang)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria of septic cardiomyopathy; 2.TCM syndrome differentiation meets the diagnostic criteria of cardiopulmonary qi deficiency and (or) heart and kidney yang deficiency and (or) yang deficiency and water flooding syndrome; 3.Aged between 18-80 years old; 4.Patients Or family members signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.ICU hospitalization time is less than 3 days; 2.History of serious underlying heart diseases; 3.Patients with advanced tumor; 4.Patients with primary liver, kidney, and blood system with serious underlying diseases; 5.Contraindications to enteral nutrition; 6.Patients with immunodeficiency; 7.Intestinal Nutritional contraindications; 8.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Immunological indicators (peripheral blood HLA-DR, CD4+T lymphocytes, CD8+T lymphocytes, natural killer cells, regulatory T cells, helper T cells 17, interleukin-10, immunoglobulin IgG, IgM) ;Serum markers of myocardial injury (cardiac troponin, creatine kinase isoenzyme, cardiac fatty acid binding protein, amino-terminal brain natriuretic peptide precursor);

Secondary

MeasureTime frame
Clinical symptom score;Serum inflammatory cytokines (interleukin-6, procalcitonin, c-reactive protein);Acute physiology and chronic health score;Multiple organ dysfunction score;28-day mortality;ICU hospital stay;

Countries

China

Contacts

Public ContactWang Ping

Beijing University of Chinese Medicine Shenzhen Hospital (Longgang)

734020972@qq.com+86 13530289607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026